- Zacks
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Eli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the disease.
- Investor's Business Daily
Biden Just Knocked Eli Lilly Stock Off Its Pedestal — Is It A Buy Or A Sell?
Is Eli Lilly stock a buy or a sell after Joe Biden called out Lilly and Novo Nordisk for high drug prices? Is LLY stock a buy or a sell?
- Yahoo財經
美股日誌｜標指納指破新關 Tesla爆上一成
美股連升兩日，標普500指數史上首次收在5,500點以上，納斯達克指數突破18,000點到數市，雙雙創新高。聯邦儲備局主席鮑威爾表示，對抗通脹的行動「取得相當大的進展」，惟未有暗示減息路線圖；Tesla上季電動車出貨量好過預期，股價急漲一成。
